← Product Code [ITI](/submissions/PM/subpart-d%E2%80%94physical-medicine-prosthetic-devices/ITI) · K991119 # TILT/RECLINER FOR POWER WHEELCHAIRS, MODEL 2G (K991119) _Invacare Corp. · ITI · Aug 19, 1999 · Physical Medicine · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/PM/subpart-d%E2%80%94physical-medicine-prosthetic-devices/ITI/K991119 ## Device Facts - **Applicant:** Invacare Corp. - **Product Code:** [ITI](/submissions/PM/subpart-d%E2%80%94physical-medicine-prosthetic-devices/ITI.md) - **Decision Date:** Aug 19, 1999 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 890.3860 - **Device Class:** Class 2 - **Review Panel:** Physical Medicine - **Attributes:** Therapeutic ## Indications for Use Its intended function and use is to aid in the pressure relief to persons confined to a powered wheelchair, by way of posterior tilt and reclining seat back. ## Device Story Battery-powered, motorized seating system for power wheelchairs; provides posterior tilt and reclining seat back to aid in pressure relief. System comprises upper and lower welded steel frame assemblies; includes recline drive actuator and tilt drive actuator. Modules (tilt and recline) operate independently; reclining system includes movable leg rest. Seat and back constructed of aluminum plates; user-selected cushions used. Operated by wheelchair user; intended for use in clinical or home environments. Device provides mechanical adjustment of seating position to redistribute pressure, potentially reducing risk of pressure sores for wheelchair-bound individuals. ## Clinical Evidence Bench testing only. Device meets requirements of ANSI/RESNA WC/14 (1991) and ISO 7176: 1993 (E) for power and control systems of electric wheelchairs. ## Technological Characteristics Battery-powered motorized seating system. Materials: welded steel (frames), aluminum plates (seat/back). Actuation: DC battery-powered electric drive actuators for tilt and recline. Form factor: modular seating system for power wheelchair base. Standards: ANSI/RESNA WC/14 (1991), ISO 7176: 1993 (E). ## Regulatory Identification A powered wheelchair is a battery-operated device with wheels that is intended for medical purposes to provide mobility to persons restricted to a sitting position. ## Predicate Devices - Tarsys Engineering Tilt/Recline Seating System ([K911151](/device/K911151.md)) - Everest & Jennings Power Recliner Wheelchair ([K914091](/device/K914091.md)) - Permobile Chairman ([K960951](/device/K960951.md)) - LaBac Adjustable Sliding Back Power Recline System ([K923363](/device/K923363.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ KG91119 AUG 19 1999 ## 510(k) SUMMARY INVACARE CORPORATION'S 510(k) PREMARKET NOTIFICATION MODEL 2G TILT/RECLINER FOR POWER WHEELCHAIRS Submitter's Name, Address, Telephone Number, Contact Person and Date Prepared. Invacare Corporation One Invacare Way Elyria, Ohio 44036 Phone: (440) 329-6000 Facsimile: (440) 365-4558 Contact Person: Edward A. Kroll, Director, TQM and Regulatory Affairs Date Prepared: March 31, 1999 Name of Device and Name/Address of Sponsor Model 2G Tilt/Recliner for Powered Wheelchairs Invacare Corporation One Invacare Way Elyria, Ohio 44036 Phone: (440) 329-6000 Facsimile: (440) 365-4558 Common or Usual Name Power Wheelchair Classification Name Wheelchair, Powered Predicate Devices Products which are substantially equivalent to the Model 2G Controls are; Everest & Jennings Power Recliner Wheelchair (K914091, November 19, 1991), the Permobile Chairman (K960951, April 30, 1997), and the LaBac Adjustable Sliding Back Power Recline System (K923363, March 24, 1993). #### Intended Use Its intended function and use is to aid in the pressure relief to persons confined to a powered wheelchair, by way of posterior tilt and reclining seat back. Technological Characteristics and Substantial Equivalence - A. Device Description The Invacare Model 2G Power Tilt/Recliner Seating System for Power Wheelchairs is a battery powered, motorized seating system designed for use with power wheelchairs. Its intended function and use is to aid in the pressure relief of persons confined to a wheelchair, by providing a method of tilting the seat and reclining the seat back. {1}------------------------------------------------ The tilting and reclining systems are separate modules and are independent of each other. As such, they will be offered as either a complete tilt/recline system, or as a separate tilt system or reclining system depending upon the users' needs. The reclining system also includes a movable leg rest feature. The system includes an upper and lower frame assembly both of which are fabricated from welded steel. The lower assembly mounts directly to the wheelchair base using standard mounting screws. It includes the recline drive actuator as well as other mechanical components used to either tilt or recline the seating system. The upper frame includes the wheelchair seat and back, as well as the tilt drive The seat and back are constructed of aluminum plates without actuator. upholstery. This allows the wheelchair user to decide the type of seat cushion that best meets their individual needs as determine by the health care provider. #### B. Substantial Equivalence Products which are substantially equivalent to the Invacare Model 2G Tilt/Recline are; Tarsys Engineering Tilt/Recline Seating System (K 911151, March 29, 1991), the Everest & Jennings Power Recliner Wheelchair (K914091, November 19, 1991), the Permobile Chairman (K960951, April 30, 1997), and the LaBac Adjustable Sliding Back Power Recline System (K923363, March 24, 1993). Each of these products are battery power, motorized, seating systems designed for use with powered wheelchairs. Performance characteristics and drive mechanisms are similar and all have the same intended function and use which is to aid in the pressure relief of persons confined to a powered wheelchair, by providing a method of tilting the seat and reclining the seat back. Additional, they are all constructed from the same basic materials. have the same basic operational principles and all use DC batteries as their source of power. ### PERFORMANCE DATA The Invacare Model 2G Tilt/Recline Seating System for Power Wheelchairs meets the applicable requirements specified in the Rehabilitation Engineering Society of North America (RESNA) Standard ANSI/RESNA WC/14 (1991) and ISO Standard ISO 7176: 1993 (E) "ISO Standard, Wheelchairs - Requirements and Test Methods for the Power and Control Systems of Electric Wheelchairs. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is an abstract symbol resembling three human profiles facing right, with three wave-like lines above them. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 AUG 1 9 1999 Mr. Edward A. Kroll Director, TQM and Regulatory Affairs Invacare® Corporation One Invacare Way P.O. Box 4028 Elyria, Ohio 44036-2125 K991119 Re: > Trade Name: Tilt/Recliner for Power Wheelchairs, Model 2G Regulatory Class: II Product Code: ITI Dated: July 26, 1999 Received: July 27, 1999 Dear Mr. Kroll: We have reviewed your Section 510(k) notification of intent to market the device referenced above, and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general control provisions of the Act. The general control provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General Regulation (21 CFR Part 820), and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {3}------------------------------------------------ Page 2 - Mr. Edward A. Kroll This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely vours. Mark N. Melleman Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ 510(k) Number (if known): TBD Device Name: Model 2G Power Tilt/Recliner Seating System for Power Wheelchairs Indications For Use: It is intended use is to aid in the pressure relief of persons confined to a power wheelchair, by providing a method of tilting the seat and reclining the seat back. Mark N Millhussen (Γon Sign-Off) D on of General Restorative Devices 510(k) Number # (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use (Per 21 CFR 801.109) OR **Over-The-Counter Use** x 991119 (Optional Format 1-2-96) --- **Source:** [https://fda.innolitics.com/submissions/PM/subpart-d%E2%80%94physical-medicine-prosthetic-devices/ITI/K991119](https://fda.innolitics.com/submissions/PM/subpart-d%E2%80%94physical-medicine-prosthetic-devices/ITI/K991119) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com